Figure 1
Figure 1. Demonstration of CXCL13 protein and CXCL13 mRNA in skin biopsy samples. (A) Hematoxylin and eosin staining of skin sample from a patient with cryoglobulinemic active vasculitis. Magnification, 10×/0.25. (B) CXCL13 protein immunofluorescence staining in skin biopsy showing feature of active vasculitis. CXCL13- specific signal appears as linear green deposits along collagen bundles. Magnification, 10×/0.25. (C) Complete absence of CXCL13 immunoreactant in skin tissue of an MC patient without active phase of vasculitis. Magnification, 10×/0.25. (D) Positive control staining in human tonsil. Magnification, 20×/0.40. (E) RT-PCR analysis of CXCL13 mRNA extracted from MC patients with and without active cryoglobulinemic vasculitis.

Demonstration of CXCL13 protein and CXCL13 mRNA in skin biopsy samples. (A) Hematoxylin and eosin staining of skin sample from a patient with cryoglobulinemic active vasculitis. Magnification, 10×/0.25. (B) CXCL13 protein immunofluorescence staining in skin biopsy showing feature of active vasculitis. CXCL13- specific signal appears as linear green deposits along collagen bundles. Magnification, 10×/0.25. (C) Complete absence of CXCL13 immunoreactant in skin tissue of an MC patient without active phase of vasculitis. Magnification, 10×/0.25. (D) Positive control staining in human tonsil. Magnification, 20×/0.40. (E) RT-PCR analysis of CXCL13 mRNA extracted from MC patients with and without active cryoglobulinemic vasculitis.

Close Modal

or Create an Account

Close Modal
Close Modal